A Study Of MCG In Cardiac Amyloidosis
A Prospective Study of Magnetocardiography for Disease Detection and Monitoring Treatment Outcomes in Amyloidosis
Mayo Clinic
500 participants
Dec 3, 2025
OBSERVATIONAL
Conditions
Summary
The primary objective of this observational study is to evaluate the utility of magnetocardiography (MCG) in diagnosing and monitoring disease progression in patients with amyloidosis, and to assess its effectiveness in comparison to other modalities, such as ECG.
Eligibility
Inclusion Criteria3
- Age ≥ 18 years on the date of consent
- Ability for participant to comply with study requirements
- Written informed consent
Exclusion Criteria6
- Pregnant or breastfeeding
- Having an active atrial fibrillation episode as seen on most current 12-lead ECG
- Active thoracic metal implants (including pacemaker, insertable cardiac monitor, or internal defibrillator).
- External electrical pads or devices (e.g. Pacer pads, ECG electrodes, heart rate patch), that must remain on patient's chest during MCG scan
- Inability to lie down in a supine/inclined position and stay still on the examination bed
- Clinical conditions that in the opinion of the Investigator would compromise the safety of the patient or ability to complete the protocol
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Magnetocardiography is a non-invasive, radiation-free imaging technique that detects the magnetic field generated by the electrical activity of the heart.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07218705